Tag: Cooley
Cooley counsels Cholesgen on co-operation deal with AstraZeneca
Cooley assisted Cholesgen on its three-year co-operation contract with AstraZeneca, the British pharmaceutical giant, led by partner Christina Zhang
Five law firms advise on largest chapter 18A listing in Hong Kong
Five law firms advised on Chinese biotechnology company Laekna’s HKD791 million chapter 18A offering, which is the largest such IPO to date this year
China Business Law Awards 2023
China Business Law Journal reveals its top performing law firms of 2022
Cooley revamps leadership, refocuses practices
Cooley has revamped its Asian leadership, appointing its first partners in charge of the Hong Kong and Beijing offices, and resolving the succession of Christina Zhang, head of the Shanghai branch for more than a decade
Cooley restructures Asian leaderships, focuses on life sciences
Cooley has revamped its Asian leadership appointing its first partners in charge of the Hong Kong and Beijing offices, and resolved the succession of Christina Zhang, head of the Shanghai branch for more than a decade
Deals of the year 2022
India Business Law Journal reveals the standout deals and disputes of 2022 and the law firms that showed their worth in successfully concluding them
Structure Therapeutics raises USD180m in ADS offering
Biopharmaceutical company Structure Therapeutics raised USD134 million in a Nasdaq listing, offering 8.95 million American depositary shares (ADS) priced at USD15 each
Deals of the year 2022
China Business Law Journal announces the most exciting China-related legal transactions and disputes of 2022
Allen & Overy adds fund and asset management partner in Shanghai
Allen & Overy has strengthened its fund and asset management practice in the Asia-Pacific region with the hire of partner Daisy Qi to the Shanghai office
Former Morrison & Foerster partner joins Cooley’s Shanghai office
Cooley’s Shanghai office welcomed partner Li Ruomu to bolster the firm’s capabilities in mergers and acquisitions, private equity and venture capital transactions
China’s YishengBio eyes US capital markets via SPAC route
Yisheng Biopharma has abandoned its Hong Kong IPO and turned instead to the Nasdaq via the SPAC route in a deal that is expected to be sealed by the first quarter of 2023
HKEX gong chimes as GoGoX goes public
China’s third largest online logistics platform has debuted on the Hong Kong bourse – a move that summoned the strike of the gong back to the trading floor
China Business Law Awards 2022
China Business Law Journal reveals the law firms that have excelled in the past year
Deals of the Year
India Business Law Journal reveals the standout deals and disputes of 2021 and the law firms that worked hard to successfully conclude them
LATEST ON VANTAGE ASIA
Knowing is half the battle
Sadaff Habib, an independent arbitrator based in Dubai, points out the major challenges in local arbitration and offers key tips for Chinese businesses
